Homing peptides as targeted delivery vehicles

Integrative Biology : Quantitative Biosciences From Nano to Macro
Pirjo Laakkonen, Kirsi Vuorinen

Abstract

Each normal organ and pathological condition appear to contain organ- or disease-specific molecular tags on its vasculature, which constitute a vascular "zip code" system. In vivo phage display has been exploited to profile this vascular heterogeneity and a number of peptides that home specifically to various normal organs or pathological conditions have been identified. These peptides have been used for targeted delivery of oligonucleotides, drugs, imaging agents, inorganic nanoparticles, liposomes, and viruses. Identification of the receptor molecules for the homing peptides has revealed novel biomarkers for target organs. In tumors many of these receptors seem to play a functional role in tumor angiogenesis. Recently, tumor homing peptides have entered clinical trials. Results from several Phase I and II trials have been reported, and a number of trials are currently ongoing or recruiting patients. In these trials no dose-limiting toxicity has occurred and all combinations of peptide-targeted therapies have been well tolerated.

References

Mar 28, 1996·Nature·R Pasqualini, E Ruoslahti
Aug 2, 1996·Journal of Medicinal Chemistry·M M JavadpourM L McLaughlin
Jun 1, 1997·Nature Biotechnology·R PasqualiniE Ruoslahti
Jul 17, 1998·The Journal of Clinical Investigation·D RajotteE Ruoslahti
Apr 16, 1999·Muscle & Nerve·T I Samoylova, B F Smith
Apr 17, 1999·The Journal of Biological Chemistry·D Rajotte, E Ruoslahti
Sep 2, 1999·Nature Medicine·H M EllerbyR Pasqualini
Jan 5, 2000·The Journal of Clinical Investigation·S Rafii
Sep 23, 2000·Nature·P Carmeliet, R K Jain
Oct 23, 2001·Developmental Dynamics : an Official Publication of the American Association of Anatomists·U OzerdemW B Stallcup
Feb 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Wadih ArapErkki Ruoslahti
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Markus Essler, Erkki Ruoslahti
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Kimmo PorkkaErkki Ruoslahti
Jun 8, 2002·Nature Medicine·Pirjo LaakkonenErkki Ruoslahti
Sep 18, 2002·Proceedings of the National Academy of Sciences of the United States of America·Maria E AkermanErkki Ruoslahti
Apr 23, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F A L M EskensA T van Oosterom
Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Raymond M SchiffelersGert Storm
Nov 26, 2003·The Journal of Cell Biology·Sven ChristianErkki Ruoslahti
Dec 12, 2003·Cancer Cell·Jason A HoffmanErkki Ruoslahti
May 11, 2004·Nature Medicine·Mikhail G KoloninWadih Arap
May 26, 2004·Biochemical Society Transactions·E Ruoslahti
Jun 16, 2004·Proceedings of the National Academy of Sciences of the United States of America·Pirjo LaakkonenErkki Ruoslahti
Jan 22, 2005·Current Opinion in Genetics & Development·Peter BalukDonald M McDonald
Sep 8, 2005·Circulation·Lianglin ZhangErkki Ruoslahti
Oct 6, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Willem J M MulderKlaas Nicolay
Nov 25, 2005·Current Pharmaceutical Design·E RuoslahtiL Zhang
Dec 6, 2005·Angiogenesis·Roni MamlukDiane R Bielenberg
Dec 16, 2005·Nature·Peter Carmeliet
Jan 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Angelina SacchiAngelo Corti
Jan 18, 2006·Annual Review of Medicine·Judah Folkman
Feb 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jan PilchErkki Ruoslahti
Jun 3, 2006·Cancer Research·Lianglin ZhangErkki Ruoslahti
Aug 4, 2006·Cancer Research·David N KragChristian Thomas

❮ Previous
Next ❯

Citations

Dec 12, 2012·Molecular Pharmaceutics·Young-Wook WonSung Wan Kim
Jan 25, 2013·Molecular Therapy. Nucleic Acids·Peter JärverMichael J Gait
Jul 31, 2012·Annals of the Rheumatic Diseases·Sarah E WytheCostantino Pitzalis
Jan 15, 2013·Journal of Amino Acids·Jyothi Thundimadathil
Oct 25, 2012·Journal of Translational Medicine·Zhi Jie Li, Chi Hin Cho
Apr 24, 2012·PloS One·Pallavi KapoorGajendra P S Raghava
Aug 28, 2012·International Journal of Nanomedicine·Ugutz UnzuetaEsther Vázquez
Jun 28, 2012·Theranostics·Marina V Backer, Joseph M Backer
Jul 12, 2014·Medical Oncology·Babak BakhshinejadMajid Sadeghizadeh
Dec 15, 2010·Journal of Drug Targeting·Thomas P Herringson, Joseph G Altin
Mar 20, 2012·Trends in Pharmacological Sciences·Nina SvensenMark Bradley
Mar 10, 2015·Advanced Drug Delivery Reviews·Prisca BoisguérinBernard Lebleu
Nov 8, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xiao-Xiang ZhangXiaoyuan Chen
Nov 5, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Oula Penate MedinaSteven M Larson
Nov 21, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Justyna M MeissnerAleksander F Sikorski
Jun 25, 2013·Journal of Peptide Science : an Official Publication of the European Peptide Society·Ji-Young KimTae-Hyoung Kim
Feb 25, 2015·Journal of Clinical Pharmacology·Dalal AlDeghaitherLouis M Weiner
Oct 25, 2016·Materials Science & Engineering. C, Materials for Biological Applications·Danyang Wang, Lin-Ping Wu
Sep 7, 2013·Biomaterials·Päivi J KinnariHélder A Santos
May 27, 2015·Nanomedicine·Renko de VriesOctavio L Franco
Jun 14, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Elisabetta GalbiatiDavide Prosperi
Aug 31, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Zhonglin LiuJames M Woolfenden
Sep 23, 2016·Molecular Pharmaceutics·Guillaume JacquotMichel Khrestchatisky
Oct 21, 2016·Bioconjugate Chemistry·Martina JezowskaMalgorzata Honcharenko
Apr 22, 2017·Journal of Biomolecular Structure & Dynamics·Selin Seda TimurR Neslihan Gürsoy
Apr 17, 2013·Scientific Reports·Kristopher MontroseGeoffrey W Krissansen
Apr 6, 2013·Scientific Reports·Arun SharmaGajendra P S Raghava
Apr 21, 2016·Dalton Transactions : an International Journal of Inorganic Chemistry·Marta SolerMiquel Costas
Dec 13, 2017·Materials·Tomasz Deptuch, Hanna Dams-Kozlowska
Mar 13, 2018·Drug Development and Industrial Pharmacy·Lorenzo Degli EspostiMichele Iafisco
Mar 14, 2012·Nucleic Acid Therapeutics·Thibault CoursindelMichael J Gait
Jun 21, 2018·Future Medicinal Chemistry·Annarita Falanga, Stefania Galdiero
Dec 28, 2018·Journal of Peptide Science : an Official Publication of the European Peptide Society·Corina CiobanasuAurelia Apetrei
Sep 11, 2014·World Journal of Gastroenterology : WJG·Babak Bakhshinejad, Majid Sadeghizadeh
Sep 7, 2019·Nanomedicine·Asmaa RedaIbrahim M El-Sherbiny
Nov 29, 2016·Nanotechnology·Ugutz UnzuetaAntonio Villaverde
Oct 30, 2012·Chembiochem : a European Journal of Chemical Biology·Morten B HansenDennis W P M Löwik
Aug 8, 2020·International Journal of Cancer. Journal International Du Cancer·Sivan Izraely, Isaac P Witz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.